Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation.
| Author | |
|---|---|
| Year of Publication | :
2018
|
| Journal | :
Gut
|
| Date Published | :
2018
|
| ISSN Number | :
0017-5749
|
| URL | :
http://gut.bmj.com/cgi/pmidlookup?view=long&pmid=29331941
|
| DOI | :
10.1136/gutjnl-2017-315766
|
| Short Title | :
Gut
|
| Download citation |